High Rise: Cannabis MSOs, Products & Market Analysis

E137 - It’s time to talk about inflation — THC inflation

07.19.2023 - By Headset, Inc.Play

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

In this episode of The High Rise, Cy and Emily dive into the intriguing phenomenon of THC inflation in the cannabis industry. They begin by addressing Organigram's recent earnings call, where CEO Beena Goldenberg highlighted the issue of falsely labeled cannabis products with exaggerated THC levels. Shockingly, nearly 50% of cannabis flower sales in Q3 were found to be labeled as containing 26% or more THC, a figure that has doubled in the last 10 months. The hosts discuss the impact of THC i...

More episodes from High Rise: Cannabis MSOs, Products & Market Analysis